AstraZeneca (AZN) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
Farallon Capital Management, L.L.C. 0.01% 21-Jul-2021 View History
HBK Investments L.P. 0% 21-Jul-2021 View History
Millennium International Management LP 0.03% 21-Jul-2021 View History
Millennium International Management LP 2.08% 20-Jul-2021 View History
Millennium International Management LP 0.53% 15-Jul-2021 View History
HBK Investments L.P. 0.51% 30-Apr-2021 View History
Farallon Capital Management, L.L.C. 0.6% 23-Apr-2021 View History
Farallon Capital Management, L.L.C. 0.5% 14-Apr-2021 View History
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today